
Weight-loss drug Ozempic to debut in India soon
Danish drug maker Novo Nordisk is set to launch in India Ozempic (semaglutide), its trailblazing once-a-week injectable brand that was originally approved to manage type 2 diabetes but found unprecedented demand for its significant benefits in patients with obesity or weight management issues. Approved first by the US FDA in 2017, Ozempic saw its global…